Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Aquaporin and brain diseases.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.
Substance Name: Simvastatin
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Education attenuates the negative impact of traumatic brain injury on cognitive status.
The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.
Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis.
Can we measure long-term treatment effects in multiple sclerosis?
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?
Stress-stimulated volitional coping competencies and depression in multiple sclerosis.
Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
Feature Selection in Order to Extract Multiple Sclerosis Lesions Automatically in 3D Brain Magnetic Resonance Images Using Combination of Support Vector Machine and Genetic Algorithm.
Advanced techniques using contrast media in neuroimaging.
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
Cytokine control of inflammation and repair in the pathology of multiple sclerosis.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Pages
« first
‹ previous
…
401
402
403
404
405
406
407
408
409
…
next ›
last »